InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.00
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.27
(
0.07%
)
Bitcoin
61,490.55
(
-2.24%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 105

Tuesday, 04/17/2018 10:39:45 AM

Tuesday, April 17, 2018 10:39:45 AM

Post# of 438
VTVT lead drug failed, as most expected, in a Ph3 Alzheimers study 4/18.

Next in the pipeline are two Ph2 candidates in Type 2 diabetes

had $11.8mn on 12/31/17. will have to raise cash during H-1/18, probably on unfavorable terms.

may be EOY tax loss candidate, at best. Put on list for EOY evaluation.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up